ライフサイエンスコーパス: vial

1 sample volume (150 nL droplets versus 10 mL vials).

2 tion of the rubber septum of the aflibercept vial.

3 reagents were deposited onto the lid of the vial.

4 ion of the detection window to the electrode vial.

5 35 days when stored under clear transparent vial.

6 suctioned and collected into a sterile empty vial.

7 monolayer compressions in a rotating closed vial.

8 ons, compared with bevacizumab directly from vial.

9 rded, was inoculated into an aerobic culture vial.

10 mpler (injector) needle pickup from a sample vial.

11 ntegrate during the transfer to the sampling vial.

12 e resin and sterilely filtered into a sealed vial.

13 rbent, and eluted with solvent into a sample vial.

14 ion of C. trachomatis in a single collection vial.

15 tion into a single BACTEC MYCO/F LYTIC (MFL) vial.

16 ein (330 attomole) loaded in the autosampler vial.

17 were related to providing <5 doses per open vial.

18 us particles) were loaded to the autosampler vial.

19 lume, pull up delay and volume in the sample vial.

20 and concentration within a single collection vial.

21 ernated with 92 previously negative ThinPrep vials.

22 assay on aliquots from reprocessed ThinPrep vials.

23 cold chain or separate adjuvant and antigen vials.

24 e close proximity to known-positive ThinPrep vials.

25 as observed in all voriconazole-supplemented vials.

26 Candida glabrata were each added to a set of vials.

27 eak and was also confirmed from unopened MPA vials.

28 vasive manner, through the side of the glass vials.

29 genera were isolated from the implicated MPA vials.

30 es in the loops are removed and collected in vials.

31 ever used but discarded as whole ampoules or vials.

32 able thickness coated on the inside of glass vials.

33 cement in BBL Port-A-Cul anaerobic transport vials.

34 ml aliquots to aerobic and anaerobic culture vials.

35 BTEXS from blood during transfer into sample vials.

36 ge lipids on a micrometer scale in picoliter vials.

37 e span in population cages, and life span in vials.

38 mixed-sex population cages and in single-sex vials.

39 y of bloodstream pathogen detection with MFL vials.

40 d sample was inoculated into each of two MFL vials.

41 xpensive, off-the-shelf, preevacuated, glass vials.

42 dified with 4 M H(2)SO(4) in sealed reaction vials.

43 analysis considered the split of bevacizumab vials.

44 als, and mandatory destruction of empty drug vials.

45 lony growth was measured from the Optisol-GS vials.

46 ut the requirement for specialized headspace vials.

47 d cell study in the pharmacy 12 hours before vial 1 was prepared.

48 njections drawn from a single pharmacy vial (vial 1).

49 The small volume of these vials (100-200 pL) allows rapid mixing of all of the sol

50 at caution is warranted when prescribing >10 vials (1000 mg) of iron dextran over a period of 6 mo.

51 e of atmospheric CO2 remaining in the loaded vial, (2) impact of helium flush, (3) sampling speed.

52 Of the 10 microL of sample per well, as with vials, 5 microL is injected into the microflow NMR probe

53 Of 228 paired vials, 51 (22%) were both positive, 172 (75%) were both

54 mated to increase from 516.1 million 1000 IU vials (95% CI 409.0 million-658.6 million) per year in 2

55 mping of the Kezzler code on all bevacizumab vials, a real-time digital verification process between

56 e accumulation of nonanal in sealed reaction vials, accounting for the other product of the acyl chai

57 In most of the nonapproved cases, a 4.8-mg vial administered to an adult patient weighing 50-100 kg

58 Staining of R-Mix vials after overnight incubation allowed initial detecti

59 the analyte during injection from the sample vial allowed greatly extended sample plug injection leng

60 e microparticles onto the side of the sample vial, allowing detection of naphthalene by surface-enhan

61 g metallic silver foil and a stainless-steel vial and ball system.

62 meters: thermostatting time and temperature, vial and desorption pressure, number of extraction cycle

63 d 14, 1 mL of solution was removed from each vial and incubated at 36 degrees C for 48 hours.

64 ations such as centrifugation-enhanced shell vial and multiwell plate cultures and the use of genetic

65 olvents followed by a transfer into a sample vial and subsequent liquid chromatography-tandem mass sp

66 ducts are eluted directly into scintillation vials and counted.

67 that this was overcome by handling in glass vials and injection using glass syringes.

68 y can be conducted entirely in scintillation vials and quantitated by addition of appropriate aqueous

69 a cold chain, waste of vaccine in multidose vials and risks associated with needle use and disposal.

70 d on the B. juncea seedlings grown in closed vials and treated with Se.

71 rococci because of oritavancin's sticking to vials and tubes.

72 egilodecakin was provided in single-use 3 mL vials and was self-administered subcutaneously by inject

73 e supernate is transferred to an autosampler vial, and 10 microL is injected into the LC-MS/MS system

74 with 500 muL of elution solvent in a sample vial, and the eluate is directly subjected to an automat

75 abscesses, 6 isolates from contaminated NECC vials, and 7 isolates unrelated to the outbreak.

76 the cavitation behavior of glass and plastic vials, and plastic had more cavitation cases.

77 g on composition (A vs A/C), number of doses/vials, and presentation.

78 Since the vials are discarded after use, no cleaning is necessary,

79 Vials are filled with CO2 and H2O and shaken in a consta

80 Septa-sealed vials are used along with commercially available disposa

81 on of intravenous anesthesia when medication vials are used for multiple patients using incorrect tec

82 at a rate of 66,700 frames per second of the vials as they underwent drop shock.

83 No specimens were positive by the shell vial assay only.

84 Application of the vial assay to the analysis of amorpha-4,11-diene synthas

85 fied with 4 of 19 subjects positive in shell vial assay, and 8 of 18 positive for CMV gene products (

86 echniques such as enzyme immunoassays, shell vial assays, and culture tube assays (year 1) to patient

87 With the collection vial at 25 atm, the trapping efficiencies of different s

88 uvant components that are stable in a single vial at sustained elevated temperatures.

89 ectively, were stored in Microbank cryogenic vials at >/=-130 degrees C in liquid nitrogen and at -70

90 ions (3.5 mL) were dripped from spiked 50-mL vials at each hour for 12 hrs.

91 ), a candidate Ebola vaccine, and stored the vials at temperatures ranging from 4 degrees C to 50 deg

92 rowave irradiation steps in the same reactor vial, avoiding the need for additional reaction purifica

93 associated with translating discovery scale vial-based batch reactions to continuous flow scale-up c

94 41 patients with bacteremia had only one MFL vial been inoculated.

95 puncture and blood collection in specialized vials by a phlebotomist along with centrifugation and re

96 wareness of how long a reconstituted measles vial can be used before it must be discarded (+14%).

97 The vials can be purchased in bulk from scientific apparatus

98 ositive samples) compared with that of shell vial cell culture (69 of 88 samples identified as positi

99 ively positive by LightCycler PCR; the shell vial cell culture assay was never positive when DNA ampl

100 enty-five patients had CMV viremia (by shell vial cell culture assay) and/or tissue-invasive disease

101 traction methods were also positive by shell vial cell culture assay.

102 tion, and equivalent costs compared to shell vial cell culture for detection of VZV indicate the need

103 targets) and by conventional tube and shell vial cell culture.

104 38; number of ocular specimens, 2) by shell vial cell cultures (MRC-5) and by LightCycler PCR.

105 mens, VZV was detected in 23 (9.1%) by shell vial cell cultures and 44 (17.4%) by LightCycler PCR dir

106 tected, 69 (78%) were detected by both shell vial cell cultures and LightCycler PCR (DNA polymerase t

107 ion of human metapneumovirus (HMPV) in shell vial centrifugation cultures (SVCC).

108 ce between the fiber and the sample into the vial clearly impacts the results obtained during HS-SPME

109 We compared five, one-vial commercial preservatives, two from Meridian Diagnos

110 i.e. 63 days when stored under amber-colored vial compared to only 35 days when stored under clear tr

111 However, when the vial contained a single HEK-293 cell transfected to expr

112 is by placing the disk into a GC autosampler vial containing 1 mL of N,O-bis(trimethylsilyl)trifluoro

113 up to 5 mL of headspace sample from a 20 mL vial containing 13 mL of aqueous solution and 5 g of NaC

114 traction device is placed in a 2 mL glass CE vial containing 550 muL of a donor solution.

115 ess this, a reusable standard gas generating vial containing pentafluorophenyl hydrazine (PFPH) has b

116 n was taken, placed into a ThinPrep Pap test vial containing PreservCyt liquid cytology medium, and t

117 In this method, a sample vial containing proteins suspended in a solubilization r

118 )Ga by adding generator eluate directly to a vial containing the cold precursors THP-PSMA and sodium

119 f various amounts of this brush initiator to vials containing a photocleavable bis-norbornene cross-l

120 in DMSO-d6 are submitted for NMR analysis in vials containing as little as 10 microL of sample.

121 Degradation rates in vials containing FeS exceeded those in Na(2)S-only contr

122 ing cholecystectomy and placed inside 120-mL vials containing ox bile.

123 volume allows exhaustive electrolysis of the vial contents with a 3-microm radius, disk-shaped carbon

124 ed after 45 min of acetone fixation of shell vial coverslips.

125 cent-antibody (DFA) staining and rapid shell vial culture (R-mix cells; Diagnostic Hybrids, Inc.

126 We analyzed a shell vial culture assay (SVA), real-time PCR, and a direct fl

127 combination of immunofluorescence and shell vial culture currently implemented at the University of

128 za A and B virus immunoassay and rapid shell vial culture were 70.3% and 98.6%, respectively.

129 ories (including amoeba co-culture and shell-vial culture) and through the use of matrix-assisted las

130 ts with CMV infection as determined by shell vial culture.

131 corporates a robotic arm for handling sample vials delivered to the laboratory, and several auxiliary

132 y applying an electric field from the sample vial directly into the capillary, with neutral analytes

133 Our study shows that a second MFL vial does not significantly increase diagnostic sensitiv

134 nolayer of granular spheres in a cylindrical vial, driven continuously by an orbital shaker and subje

135 Here, we describe an in-vial dual extraction (IVDE) method and a direct injectio

136 ntains a constant position of the HF in a CE vial during extraction and simultaneously guides the inj

137 ide mass in the headspace of a closed sample vial during the bacteria growth.

138 d since solutions were in borosilicate glass vials during irradiation resulting from increasingly low

139 eled antibodies can be predried to the assay vials, e.g., microtiter plate wells, and readout is read

140 Two vials each were supplemented with amphotericin B at conc

141 supplied by a commercial manufacturer (bulk vial eluted from a generator).

142 In each of 27 vials examined, cells had the rpoS start codon UUG inste

143 ther organism in amphotericin B-supplemented vials, except at 0.25x and 0.5x MIC on day 2, when viabl

144 An in-vial extraction and UHPLC-MS analysis method was first d

145 atrix of leucine, high-yield, free-flowing, "vial-fillable" powders of bacteria (including M. smegmat

146 upernatant was cleaned-up using d-SPE and in-vial filtration with a combination of anhydrous CaCl2 (1

147 In-vial filtration with dispersive solid-phase extraction (

148 rried out by applying pressure to the sample vial followed by the subsequent sweeping and separation

149 muL of the sample in and out of the tip in a vial for approximately 1 min.

150 olyzed, and derivatized in a single reaction vial for routine analysis by GC-MS.

151 yl-tryptophan in nitrogen gas-sparged Teflon vials for 0-144 h at 110 degrees C.

152 s compared to viral culture with R-Mix shell vials for 455 nasal-wash or nasal-aspirate specimens.

153 andard 96-/384-well plates, Petri dishes, or vials for cloning, PCR, and other single-cell biochemica

154 lapses included using single-dose medication vials for more than 1 patient (18/64; 28.1%; 95% CI, 18.

155 the national switch date, removing any tOPV vials found.

156 After 24 hours, 1 vial from each pair was exposed to light for the remaind

157 nondestructively verify the quality of every vial from the point of release to the point of care.

158 Twenty-seven tissue product vials from a donor were distributed to facilities in 7 s

159 Unopened heparin vials from facilities that reported reactions were teste

160 isposal of tOPV included removal of all tOPV vials from the cold chain, placement in appropriate bags

161 was detected by culture and qPCR in 2 unused vials from the donor.

162 lready in the cells from the original frozen vials from the same ATCC lot, however, STR markers did n

163 buted to facilities in 7 states; at least 20 vials from this donor were used in 14 patients.

164 me profiles of dissolved O(2) in each sample vial, from which Threshold Time of sensor signal was det

165 ns, fill volumes, drop heights, and internal vial geometries.

166 mab sampled directly from the original glass vial had particle counts of 63,839 +/- 349/mL.

167 ted patients who received doses from 6 other vials had acute HCV infection.

168 Preevacuated vials have been used by others for the isotopic analysis

169 /grafting) and emerged from their cells into vials held in an incubator at 34C.

170 ased with exposure to lot 06292012@26, older vials, higher doses, multiple procedures, and translamin

171 Inoculation of one vial, however, would be expected to reduce the sensitivi

172 POC test using a drop of blood comprising a vial immunosensor, artificial nanozyme platinum/gold cor

173 that a potential problem with the TB antigen vials in a certain tube lot was the likely cause of the

174 y adjusts drug concentrations inside culture vials in order to maintain a constant drug-induced inhib

175 gradation reactions were also carried out in vials (in vitro) with a total reaction volume of 400 muL

176 rements of ATP and glucose in pharmaceutical vials (including mixtures of ATP and glucose) were carri

177 Medication vials incorporating electronic monitor circuits in their

178 philic and hydrophilic layer within a single vial insert, we showed that analytical variation was dec

179 was adapted to use 1.5 mL glass autosampler vials instead, which facilitated sampling and circumvent

180 Vial-inversion tests and rheology show that ThT increase

181 The vial is agitated at 750 rpm for 10 min, and the resultin

182 tion conditions that exist in the adenovirus vial, is obtained by direct boundary modeling of the AUC

183 >99% similarity between patient and unopened vial isolates.

184 led by the pharmacy; examination of unopened vials later revealed fungus.

185 They developed higher vial loads, more severe lung pathology, and greater infl

186 horesis (CE) system with flow-through sample vial made in-house and action control programming was as

187 ng were investigated to study the effects of vial materials, solutions, fill volumes, drop heights, a

188 dling and accidental dropping of therapeutic vials may cause cavitation, aggregation, and particle fo

189 t transfer to the (89)Zr-containing reaction vial, mixing of the reagents followed by a 60-min reacti

190 Puncturing single-use vials multiple times and pooling preservative-free epoet

191 ral companies and are often presented as one-vial, non-mercuric chloride fixatives that aim at perfor

192 In sealed vials, O2 concentrations in solutions containing liver s

193 ial of drug can be avoided by using a single vial of bevacizumab for each eye or by following strict

194 r 797 requirements when compounding a single vial of bevacizumab into multiple syringes.

195 b-containing syringes prepared from the same vial of drug can be avoided by using a single vial of be

196 Because a vial of frozen cells can now provide the capacity to pro

197 The median time from the first vial of idarucizumab to surgery or procedures was less t

198 ho inappropriately used a single-patient-use vial of propofol for multiple patients.

199 A 100-microg vial of toxin taken from the same manufacturer's lot as

200 lectrode, moving sequentially through the 24 vials of a standard 6 x 4 microtiter plate.

201 was isolated from pooled epoetin alfa, empty vials of epoetin alfa that had been pooled, antibacteria

202 revealed that preservative-free, single-use vials of epoetin alfa were punctured multiple times, and

203 Vials of heparin manufactured by Baxter from facilities

204 Bills for <or=10 vials of iron over 6 mo also showed no significant assoc

205 in multivariable analysis, bills for <or=10 vials of iron over 6 mo showed no adverse effect on surv

206 nkage between clinical isolates and injected vials of MPA, and described significant features of the

207 cy study measured fungal colony growth in 10 vials of Optisol-GS supplemented with different concentr

208 fungal colony-forming units from inoculated vials of optisol-GS taken at 2 different processing temp

209 Twenty vials of Optisol-GS were supplemented with either vorico

210 rs of research-grade donor corneas and 20-mL vials of Optisol-GS.

211 btained what appear to be the last available vials of poliovaccine produced in 1955.

212 Twelve current vials of poliovaccines tested uniformly negative for SV4

213 d the impact of incorporation of R-Mix shell vials on the sensitivity and time to detection of seven

214 icle sizes into several different collection vials on the tens of milligrams scale.

215 duced to inserting the DBS punch into the CE vial only.

216 n aqueous solution of gentamicin sulphate in vials or ampoules and requires health care workers to be

217 to perform either rapid diagnostics (single vial) or the high-throughput (96-well plate) analysis of

218 C/Y/W-135-DT meningococcal conjugate vaccine vial, or in a final formulated bulk, accurate identifica

219 s was limited to sharps waste, empty vaccine vials, or vaccines that had expired or were no longer us

220 Prescribing iron in quantities of <or=10 vials over 6 mo had no association with an elevated risk

221 re is formulated in glass gas chromatography vials, overlaid with organic solvent such as ethyl aceta

222 e discard vial versus 10.5% for the standard vial (P = 0.90).

223 We evaluated a single-vial peptide vaccine consisting of nine HLA-A2 supertype

224 in one ready-to-use, fixed-dose combination vial (pertuzumab, trastuzumab, and hyaluronidase-zzxf) w

225 3.2 x 103 aseptic, purified, cryopreserved, vialed Plasmodium falciparum (Pf) strain NF54 sporozoite

226 cines (28%), lack of knowledge on multi-dose vial policy (30%) and age of IPV administration (8%).

227 ction are lower, implementing the multi-dose vial policy, and encouraging the use of fractional dose

228 nt of LightCycler PCR results with all shell vial positive results indicate the potential for routine

229 Among the 13 shell vial-positive lower respiratory samples, the percent sen

230 ctions drawn from select radiopharmaceutical vials prepared on October 14-15, 2004, at a single nucle

231 The effects of different collection vial pressures were evaluated.

232 Ninety-two ThinPrep vials previously positive for high-risk human papillomav

233 f our knowledge, the standard gas generating vial proposed in this work is the first documented devic

234 simple, 1-step, room-temperature syringe-and-vial radiolabeling of (68)Ga radiopharmaceuticals.

235 0.06, 0.12, or 0.225 mug/mL; the remaining 2 vials received no C albicans inoculation and no antifung

236 s as target analytes demonstrated intrabatch vial reproducibility (2% relative standard deviation (RS

237 l assay, loss of C60 due to sorption to test vials resulted in the reduction of exposure-solution con

238 n composition was observed in commercial SPT vials resulting in a patient-dependent ability to activa

239 ant levels of MTBE were identified in sample vial septa that use poly(dimethylsiloxane) (PDMS)-based

240 m.s(-1) through fish scales, forced through vial septa, and employed in a targeted study of polyunsa

241 ainer stoppers, syringe plungers, and sample vial septa.

242 ues of 15-200 mg Pt/L), but also in a double-vial setup, separating cells from PtNPs, thus demonstrat

243 ) when compared with none, but bills for >10 vials showed a statistically significant elevated rate o

244 , 0.83 to 1.03; P = 0.15), but bills for >10 vials showed statistically significant elevated risk (ad

245 ECOFIX is a single-vial stool preservative that is both formalin- and mercu

246 nt flies fall when climbing the walls of the vials, suggesting a defect in grip strength, and repeat

247 A bridged two-vial system aminocarbonylation protocol where Mo(CO)(6)

248 However, NIR has been used as a single-vial technique and thus is not representative of the ent

249 ltivation in Vero cell cultures by the shell vial technique with individual A. cooperi ticks resulted

250 acking on-site molecular capabilities, shell vial techniques can rapidly (about 1 day) confirm negati

251 ling 0.2 mL of cold (4 degrees C) cider in a vial that is passed in an ultrasonic bath for 10 min at

252 eactions are performed in 10 mL borosilicate vials that are sealed with a silicone cap and Teflon sep

253 elevation of the pressure on the collection vial, the flow may be reduced and trapping efficiency im

254 When mixed together in the same vial, the progeny of species I replicate preferentially

255 For 5 of 27 (19%) vials, the final disposition could not be confirmed.

256 tal variance both within and among replicate vials, the significance of genetic variation among wild-

257 required, except for the transfer of the CE vial to the CE autosampler.

258 idyl)propane (dpp) lead in a single reaction vial to the simultaneous formation of three different si

259 s to ensure long-term stability and separate vials to enable bedside mixing of antigen and adjuvant.

260 Thus, we were able to use three buffer vials to perform CE experiments in the capillary by appl

261 cturer provided vaccine and placebo in coded vials to preserve blinding.

262 va was collected from subjects into separate vials under resting conditions and during chewing-stimul

263 The two phases in the vial, upper and lower, underwent HPLC-QTOF analysis on i

264 , with resulting contamination of medication vials used for subsequent patients, likely resulted in v

265 Validation of the vial using C4-C9 linear aldehyde standards as target ana

266 Biodegradation tests were conducted in 20 mL vials using environmental water samples as inocula.

267 ysaccharide concentrations of A/C/Y/W-135 in vialed vaccine or from formulated final bulks.

268 Overall CR were 10.9% for the discard vial versus 10.5% for the standard vial (P = 0.90).

269 50 muL donor phase at the bottom of a sample vial, via an immiscible organic filter phase, into a 2 m

270 ical injections drawn from a single pharmacy vial (vial 1).

271 n by either precipitation or sorption to the vial walls.

272 Wastage per 5-dose vaccine vial was above the recommended 30% in 20 health faciliti

273 Finally, the PFPH-generating vial was applied to the monitoring of volatile aldehydes

274 inated in 33 (5.1%); and only the "standard" vial was contaminated in 31 (4.7%).

275 nated in 38 pairs (5.8%); only the "discard" vial was contaminated in 33 (5.1%); and only the "standa

276 g system using ethylene vinyl acetate coated vials was developed to eliminate the incomplete dissolut

277 say for the detection of biotin in picoliter vials was developed using the photoprotein aequorin as t

278 mes, and residual epoetin alfa from multiple vials was pooled and administered to patients.

279 ter (containing 3g of NaCl in a 40-mL sample-vial) was microwave irradiated at 80 W for 5 min.

280 In these vials, we detected and sequenced SV40 containing only on

281 Mixed Mv1Lu and A549 cells in a single shell vial were synergistic for detection of influenza virus A

282 les with known positive results by CMV shell vial were tested by each PCR method.

283 t of 653 IVC-drawn blood culture pairs, both vials were contaminated in 38 pairs (5.8%); only the "di

284 m the conjugates at the bottom of the sample vials were easily visualized by the naked eye under ultr

285 The vials were fabricated from fused-silica capillaries that

286 rate experiments, aliquots from 236 ThinPrep vials were forwarded for tandem analysis with and withou

287 ing a smaller fill volume or larger diameter vials were found to mitigate cavitation across drop heig

288 The vials were incubated for 72 h, and aliquots were removed

289 The vials were placed inside a water-filled phantom and were

290 In total, 821 ThinPrep vials were tested using both assays.

291 In this study, R-Mix shell vials were used as part of the culture of 3803 respirato

292 standard method (ISO, 18593:2018) in sensor vials, which were then incubated at 30 degrees C and mea

293 he RT-LAMP reagents were added to the sample vial, while CRISPR Cas12a reagents were deposited onto t

294 ltic pump, control unit, customized transfer vial with a drain port, and an autosampler arm to delive

295 the neurotransmitter dopamine in a picoliter vial with electrochemical techniques.

296 The system uses disposable swab vials with phosphorescent oxygen sensors integrated in t

297 Water containing EDB was incubated in sealed vials with various combinations of Na(2)S (<0.7 mM) and

298 on IFNalpha2b (a portion of 10 million IU/ml vial) with follow-up every 1 to 3 months.

299 monitor the concentration of analyte in the vial without depleting its contents.

300 All previously negative ThinPrep vials yielded a negative result following routine automa